[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363365-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363365-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","choice-and-death-analysis-of-medical-assistance-in-dying-for-head-and-neck-cancer-in-ontario","Choice and Death - Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario","","Objective: Limited information exists on how many patients with head and neck cancer (HNC) receive Medical Assistance in Dying (MAiD). The study assesses prevalence, disease characteristics, and the nature of the desire for MAiD among HNC patients who underwent the process in Ontario, aiming to understand this population and identify gaps in care. Methods: Retrospective cross-sectional analysis covering June 17, 2016 to December 31, 2022. Data were provided by the Office of the Chief Coroner, Ontario, Canada.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/choice-and-death-analysis-of-medical-assistance-in-dying-for-head-and-neck-cancer-in-ontario/363365/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/choice-and-death-analysis-of-medical-assistance-in-dying-for-head-and-neck-cancer-in-ontario/363365.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary objective of the study?","Question",{"text":63,"@type":64},"To describe how MAiD uptake occurs among patients with head and neck cancer in Ontario, including prevalence, disease characteristics, and the nature of the desire for MAiD.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study conducted and what data source was used?",{"text":68,"@type":64},"The study used a retrospective cross-sectional design for June 17, 2016 to December 31, 2022, using data received from the Office of the Chief Coroner, Ontario, Canada.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about MAiD patients with head and neck cancer?",{"text":72,"@type":64},"A total of 356 persons received MAiD; the most common primary tumor site was the oral cavity, the leading reported reason involved inadequate symptom control besides pain, and uptake predictions indicated a linear year-by-year increase.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363365,1790198323,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","The Laryngoscope   \n ORIGINAL REPORT  OPEN ACCESS   \nChoice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario  \nTanika Curry1  | Emily Wener1 | Michael Odell1 | Lisa Caulley2 | Rashi Ramchandani3 | Alyssa Grant2 | Kednapa Thavorn2  | Andrea Lasso2  | Shaun Kilty1,2  \n1Department of Otolaryngology—Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada | 2Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario, Canada | 3Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada  \nCorrespondence: Shaun Kilty ([skilty@toh.ca](skilty@toh.ca))  \nReceived: 3 September 2025 | Revised: 13 January 2026 | Accepted: 20 January 2026  \nKeywords: head and neck cancer | laryngeal cancer | Medical Assistance in Dying | oral cavity cancer | pain control  \nABSTRACT  \nObjective: There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care. Methods: This is a retrospective cross-sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada.  \nResults: Three hundred and fifty-six persons received MAiD. The average age was 72.4years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%) . The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%) . The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoodsand in large urban centers. Future prediction of MAiD uptake shows a linear year-by-year increase.  \nConclusion: The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent.  \nLevel of Evidence: 4  \n1 | Introduction  \nCanada's Medical Assistance in Dying (MAiD) became legal in Canada when Bill C-14 received Royal Assent on June 17, 2016 to establish the legal eligibility criteria and procedural safeguards for those seeking MAiD [1] .  \nHead and neck cancers (HNCs) can be complex and, when advanced, debilitating and can significantly impact a patient's quality of life. Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies involving the upper aerodigestive  \ntract (specifically divided into the following subsites: oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands) that represent the seventh most common cancer diagnosed worldwide [2] . With the rising incidence of HNC there is the concern about the increasing burden of disease. For patients with incurable HNC the end-of-life phase is uniquely challenging due to the anatomical and functional location of tumors as disease in the head and neck region may result in a number of issues such as airway compromise, swallowing dysfunction, pain, disfigurement, and other symptoms that significantly reduce quality of life [3] .  \n\n| All authors contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2026 The Author(s) . The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Soc","cbCainTTQmSe81Fc","https://ap.wps.com/l/cbCainTTQmSe81Fc","pdf",553979,"English","# Abstract\n# Introduction\n## Medical Assistance in Dying legal context\n## Head and neck cancer burden and end-of-life challenges\n## MAiD access reporting and jurisdictional context","[{\"question\":\"What is the primary objective of the study?\",\"answer\":\"To describe how MAiD uptake occurs among patients with head and neck cancer in Ontario, including prevalence, disease characteristics, and the nature of the desire for MAiD.\"},{\"question\":\"How was the study conducted and what data source was used?\",\"answer\":\"The study used a retrospective cross-sectional design for June 17, 2016 to December 31, 2022, using data received from the Office of the Chief Coroner, Ontario, Canada.\"},{\"question\":\"What did the results show about MAiD patients with head and neck cancer?\",\"answer\":\"A total of 356 persons received MAiD; the most common primary tumor site was the oral cavity, the leading reported reason involved inadequate symptom control besides pain, and uptake predictions indicated a linear year-by-year increase.\"}]","Choice and Death - Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario | PDF",1790150949,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b347416f21ee1635918a4986c8bc44f1.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ddd5b5a262fc482d2f4f2d3ae7daf9f.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b533528d33c2a5ee66254c3573ffb40.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc081f1f72b6ec89d19595f2b88c335d.webp",980,1287]